Genta/Posacon/Mometa Eardrops
139 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
139
Total Reports
1
Deaths Reported
70.0%
Death Rate
Active Ingredients
Genta/Posacon/Mometa Eardrops
Administration Routes
Auricular (Otic)TopicalUnknownOral
Species Affected
Dog 136
Cat 2
Unknown 1
Most Affected Breeds
Crossbred Canine/dog 44
Retriever - Labrador 15
Bulldog - French 10
Unknown 5
Retriever - Golden 5
Shepherd Dog - German 4
Pug 3
Pit Bull 3
Bichon Frise 3
Dog (unknown) 3
Most Reported Reactions
Lack of efficacy - NOS 37
Lack of efficacy (bacteria) - NOS 35
Lack of efficacy (fungi) - NOS 28
Deafness 12
Head shake - ear disorder 9
Ear canal inflammation 8
Lethargy (see also Central nervous system depression in Neurological) 8
Head tilt - ear disorder 8
Medication error NOS 7
Behavioural disorder NOS 6
Ear discharge 6
Ear pain 6
Outcome Breakdown
Ongoing
101 (73.2%)
Outcome Unknown
17 (12.3%)
Recovered with Sequela
13 (9.4%)
Recovered/Normal
6 (4.3%)
Died
1 (0.7%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.